Abivax SA (ABVX)
113.35
-0.95
(-0.83%)
USD |
NASDAQ |
Aug 28, 16:00
113.39
+0.04
(+0.04%)
After-Hours: 20:00
Abivax Net Income (Quarterly) : -56.70M for March 31, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | -56.70M |
| December 31, 2025 | -95.40M |
| September 30, 2025 | -179.22M |
| Date | Value |
|---|---|
| June 30, 2025 | -54.88M |
| March 31, 2025 | -55.12M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Poxel SA | -- |
| OSE Immunotherapeutics SA | -- |
| Cogent Biosciences, Inc. | -96.40M |
| Compass Pathways Plc | -254.25M |
| Vera Therapeutics, Inc. | -109.47M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 56.70M |
| EPS Diluted (Quarterly) | -0.7181 |
| Enterprise Value | 8.461B |
| Earnings Yield | -4.64% |
| Normalized Earnings Yield | -4.085 |